|
2020
|
Invention
|
Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compound. Vitam... |
|
2018
|
Invention
|
Recombinant microorganism and method of producing pyridoxamine or salt thereof using recombinant ... |
|
|
Invention
|
Recombinant microorganism, method of producing pyridoxamine or salt thereof using recombinant mic... |
|
|
Invention
|
Recombinant microorganism, and production method of pyridoxamine, or salt thereof, using said rec... |
|
|
Invention
|
Recombinant microorganism, production method of pyridoxamine, or salt thereof, using recombinant ... |
|
2017
|
Invention
|
Composition used to improve symptoms of autism spectrum disorder, and method using same for impro... |
|
2015
|
Invention
|
Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compound.
Vita... |
|
2014
|
Invention
|
Detection and treatment of schizophrenia.
The present invention provides a method for diagnosing... |
|
|
Invention
|
Plasminogen activator inhibitor-1 inhibitor.
The present invention provides a novel compound hav... |
|
|
Invention
|
Use for pai-1 inhibitor. Provided is a novel use of a plasminogen activator inhibitor-1 inhibitor... |
|
|
Invention
|
Novel use for pai-1 inhibitor. Provided is a novel use for a plasminogen activator-1 inhibitor (P... |
|
2010
|
Invention
|
Plasminogen activator inhibitor-1 inhibitor. The present invention provides a novel compound havi... |
|
|
Invention
|
Plasminogen activator inhibitor-1 inhibitor. The present invention provides a novel compoun... |
|
|
Invention
|
Plasminogen activator inhibitor-1 inhibitor. Provided are a novel compound which exhibits a plasm... |
|
2009
|
Invention
|
Inhibitor of plasminogen activator inhibitor-1. The present invention relates to a novel compound... |
|
|
Invention
|
Inhibitor of plasminogen activator inhibitor-1. Disclosed is a novel compound having an inhibitor... |
|
2008
|
Invention
|
Detection and treatment of schizophrenia. The present invention provides a method for diagnosing ... |
|
|
Invention
|
Detection and treatment of schizophrenia. Disclosed is a schizophrenia detection method. Also dis... |
|
|
Invention
|
Plasminogen activator inhibitor-1 inhibitor. The present invention relates to an inhibitor of pla... |
|
|
Invention
|
Inhibitor of plasminogen activator inhibitor-1. An inhibitor of plasminogen activator inhibitor-1... |
|
2007
|
Invention
|
Plasminogen activator inhibitor-1 inhibitor. Disclosed are a PAI-1 inhibitor and a pharmaceutical... |
|
2006
|
Invention
|
Phenylene derivative. It is intended to provide a novel phenylene derivative represented by the f... |
|
|
Invention
|
Carbonyl compound remover. ⏧PROBLEMS] To provide a carbonyl compound remover with a high car... |
|
2004
|
Invention
|
Megsin/rage/inos-overexpressing renal disease model animals and methods for evaluating compounds ... |
|
|
Invention
|
Megsin/rage/inos overexpressing renaldisease model animals and methods for evaluating compounds u... |
|
|
Invention
|
Phenylene derivative having tetrazole ring or thiazolidinedione ring. The present invention provi... |
|
|
Invention
|
Phenylene derivative having tetrazole ring or thiazolidinedione ring.
Disclosed are a ... |
|
|
Invention
|
Phenylene derivative having tetrazole ring or thiazolidinedione ring. Disclosed are a compound re... |
|
|
Invention
|
Establishment of disease nerve cells by combining method of highly efficiently inducing nerve dif... |
